Antidiabetic Potential of Nypa fruticans Fronds: Inhibition of α-Amylase, α-Glucosidase, and Glucose Absorption In Vivo
Danang Raharjo 1, Haryoto 1*, Tanti Azizah Sujono 1, Heng Yen Khong 2, 3 *
Journal of Angiotherapy 8(10) 1-8 https://doi.org/10.25163/angiotherapy.8109965
Submitted: 03 July 2024 Revised: 02 October 2024 Published: 07 October 2024
Abstract
Background: Diabetes mellitus (DM) results from insulin resistance or impaired insulin secretion, leading to hyperglycemia, which, in advanced stages, causes macrovascular and microvascular complications. Effective management of postprandial hyperglycemia is critical to reducing these complications. Inhibition of carbohydrate hydrolyzing enzymes such as α-amylase and α-glucosidase offers a therapeutic approach for controlling postprandial glucose levels. While acarbose is a known inhibitor of these enzymes, its long-term use can cause gastrointestinal side effects. Therefore, alternative treatments, such as medicinal plants, are being explored. This study focuses on the antidiabetic potential of the Nipah frond (Nypa fruticans Wurmb), a traditional remedy, which is believed to inhibit glucose absorption and carbohydrate degradation. Methods; Nipah frond powder was extracted using ethanol through maceration. Phytochemical screening was conducted to detect bioactive compounds, and in vivo and in vitro assays were performed to evaluate antidiabetic properties. The inverted intestinal pouch technique assessed glucose absorption, while the Oral Glucose Tolerance Test (OGTT) was conducted on male Wistar rats. Enzyme inhibition assays for α-amylase and α-glucosidase were carried out to measure the extract's effectiveness in inhibiting carbohydrate degradation. Results: In vitro tests demonstrated that the ethanol extract exhibited inhibitory activity against both α-amylase and α-glucosidase enzymes, with IC50 values of 38.493 ± 0.900 ppm and 40.401 ± 0.558 ppm, respectively. In vivo studies using the everted sac technique showed that the extract reduced glucose absorption by 74.10% compared to the control group, similar to acarbose. In the OGTT, administration of 1000 mg/kg BW of Nipah frond extract significantly reduced postprandial glucose levels, with an area under the curve (AUC) comparable to glibenclamide. Conclusion: The ethanol extract of Nypa fruticans fronds demonstrated significant antidiabetic activity by inhibiting α-amylase and α-glucosidase, reducing glucose absorption, and suppressing postprandial hyperglycemia in vivo.
Keywords: Nypa fruticans, α-amylase inhibition, α-glucosidase inhibition, Postprandial Hyperglycemia, Antidiabetic Plants
References
Al-Ishaq, RK, Abotaleb, M, Kubatka, P, Kajo, K & Büsselberg, D (2019). Flavonoids and their anti-diabetic effects: Cellular mechanisms and effects to improve blood sugar levels. Biomolecules, 9(9), 430.
Aslam, R, Suhail, S, Sajid, R & bin Younis, B (2022). Type 2 Diabetes Mellitus (T2DM) in Pakistan: Prevalence, Trends and Management Strategies. Annals of King Edward Medical University, 28(2), 247–254.
Aulia, V, Pachira, P, Olvi, M & Simamora, CJK (2021). Nipah Resistant Starch (Nypa fruticans): Modulation of Normal Microflora of Digestion, and Control of Diabetes. BIOEDUSCIENCE, 5(3), 224–233.
Bhatnagar, A & Mishra, A (2022). α-Glucosidase inhibitors for diabetes/blood sugar regulation. In Natural products as enzyme inhibitors: An industrial perspective (pp. 269–283). Springer.
David-Silva, A, Esteves, JV, Morais, MRPT, Freitas, HS, Zorn, TM, Correa-Giannella, ML & Machado, UF (2020). Dual SGLT1/SGLT2 inhibitor phlorizin ameliorates non-alcoholic fatty liver disease and hepatic glucose production in type 2 diabetic mice. Diabetes, Metabolic Syndrome and Obesity, 739–751.
Fisher, M (2022). Acarbose and alpha glucosidase inhibitors. Diabetes Drug Notes, 229–238.
Gong, L, Feng, D, Wang, T, Ren, Y, Liu, Y & Wang, J (2020). Inhibitors of α-amylase and α-glucosidase: Potential linkage for whole cereal foods on prevention of hyperglycemia. Food Science & Nutrition, 8(12), 6320–6337.
Haryoto, Alysa, VA, Peni, I, Cita, HM & Khong, HY (2023). Inhibitory Activity of Enzyme α-Glucosidase Ethanol Extract Combination of Mareme Plant (Glochidion arborescens (Müll. Arg.) Boerl.) and Leaves of the. Journal of Angiotherpay, 7(1), 1–7.
Jadhav, R & Puchchakayala, G (2012). Hypoglycemic and antidiabetic activity of flavonoids: boswellic acid, ellagic acid, quercetin, rutin on streptozotocin-nicotinamide induced type 2 diabetic rats. Group, 1, 100g.
Klisic, A, Kavaric, N, Vujcic, S, Mihajlovic, M, Zeljkovic, A, Ivanisevic, J, Spasojevic-Kalimanovska, V, Ninic, A, Kotur-Stevuljevic, J & Vekic, J (2020). Inverse association between serum endocan levels and small LDL and HDL particles in patients with type 2 diabetes mellitus. European Review for Medical & Pharmacological Sciences, 24(15).
Magaña-Barajas, E, Buitimea-Cantúa, GV, Hernández-Morales, A, Torres-Pelayo, V, Vázquez-Martínez, J & Buitimea-Cantúa, NE (2021). In vitro α-amylase and α-glucosidase enzyme inhibition and antioxidant activity by capsaicin and piperine from Capsicum chinense and Piper nigrum fruits. Journal of Environmental Science and Health, Part B, 56(3), 282–291.
Mahomoodally, MF, Subratty, AH, Gurib-Fakim, A, Choudhary, MI & Nahar Khan, S (2012). Traditional medicinal herbs and food plants have the potential to inhibit key carbohydrate hydrolyzing enzymes in vitro and reduce postprandial blood glucose peaks in vivo: the Scientific World Journal, 2012(1), 285284.
Maryam, S, Suhaenah, A & Amrullah, NF (2020). Uji Aktivitas Penghambatan Enzim Α-Glukosidase Ekstrak Etanol Biji Buah Alpukat Sangrai (Persea americana Mill.) Secara In Vitro. As-Syifaa Jurnal Ilmiah, 12(1), 51–56.
Niisato, N & Marunaka, Y (2023). Therapeutic potential of multifunctional myricetin for treatment of type 2 diabetes mellitus. Frontiers in Nutrition, 10, 1175660.
Nor, AY, Mariam, A, Al-Hindi, B, Tri, W, Yam, M, Roziahanim, M, Khairul, N & Mohd, ZA (2015). Aqueous extract of Nypa fruticans Wurmb. vinegar alleviates postprandial hyperglycemia in normoglycemic rats. Nutrients, 7(8), 7012–7026.
Ouassou, H, Zahidi, T, Bouknana, S, Bouhrim, M, Mekhfi, H, Ziyyat, A, Legssyer, abdekhaleq, Aziz, M & Bnouham, M (2018). Inhibition of α-Glucosidase, Intestinal Glucose Absorption, and Antidiabetic Properties by Caralluma europaea. Evidence-Based Complementary and Alternative Medicine, 2018(1), 9589472.
Reza, H, Haq, WM, Das, AK, Rahman, S, Jahan, R & Rahmatullah, M (2011). Anti-hyperglycemic and antinociceptive activity of methanol leaf and stem extract of Nypa fruticans Wurmb. Pak J Pharm Sci, 24(4), 485–488.
Rubianti, I, Azmin, N & Nasir, M (2022). Analisis Skrining Fitokimia Ekstrak Etanol Daun Golka (Ageratum conyziodes) Sebagai Tumbuhan Obat Tradisional Masyarakat Bima. JUSTER: Jurnal Sains Dan Terapan, 1(2), 7–12.
Saha, S & Paul, S (2019). A review on phytochemical constituents and pharmacological properties of Enhydra fluctuans Lour. Journal of Pharmacognosy and Phytochemistry, 8(2), 887–893.
Shanak, S, Saad, B & Zaid, H (2019). Metabolic and epigenetic action mechanisms of antidiabetic medicinal plants. Evidence-Based Complementary and Alternative Medicine, 2019(1), 3583067.
Sok Yen, F, Shu Qin, C, Tan Shi Xuan, S, Jia Ying, P, Yi Le, H, Darmarajan, T, Gunasekaran, B & Salvamani, S (2021). Hypoglycemic effects of plant flavonoids: a review. Evidence-Based Complementary and Alternative Medicine, 2021(1), 2057333.
Yusoff, NA, Lim, V, Al-Hindi, B, Abdul Razak, KN, Widyawati, T, Anggraini, DR, Ahmad, M & Asmawi, MZ (2017). Nypa fruticans Wurmb. Vinegar’s aqueous extract stimulates insulin secretion and exerts hepatoprotective effect on STZ-induced diabetic rats. Nutrients, 9(9), 925.
View Dimensions
View Altmetric
Save
Citation
View
Share